Crohn Disease: all 1,923 studies

Page 14 of 20. Open to participants first (467), then studies with results posted, then the rest; newest registration first within each.

• Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Recurrence in Crohn's DiseaseStatus unknownNCT03185611Phase 3
• Comparison of Partial and Exclusive Enteral Nutrition in the Treatment of Active Childhood-onset Crohn's DiseaseStatus unknownNCT03176875Not applicable
• Chronic Inflammatory Disease, Lifestyle and Treatment ResponseCompletedNCT03173144
• Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease PatientsStatus unknownNCT03172377Phase 4
• Mesenteric Sparing for the Prevention of Recurrent Crohn's DiseaseTerminatedNCT03172143Not applicable
• CD-TREAT Diet: a Novel Therapy for Active Luminal Crohn's DiseaseCompletedNCT03171246Not applicable
• High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving RemicadeActive, not recruitingNCT03162432Phase 3
• A Treat-to-target Strategy Using Pan-enteric Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD).CompletedNCT03161886Not applicable
• Surgically Resected Crohn's Disease Patients: Prognostic Factors for Re-operation and New Score BuildingStatus unknownNCT03150238
• Fecal Calprotectin Collection ProtocolCompletedNCT03143517
• Advanced Non-Invasive Diagnostics in Inflammatory Bowel DiseaseCompletedNCT03134586Not applicable
• The IMAGINE-SPOR CIHR Chronic Disease NetworkStatus unknownNCT03131414
• Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s DiseaseStatus unknownNCT03108326
• A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's DiseaseActive, not recruitingNCT03105102Phase 3
• MRI Differentiating Gut TB and Crohn'sCompletedNCT03096379
• Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel DiseaseStatus unknownNCT03091309Not applicable
• Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging MarketsCompletedNCT03090139
• Personalising Anti-TNF Therapy in Crohns Disease (PANTS)Status unknownNCT03088449
• Immune Modulation From Trichuris SuisCompletedNCT03079700
• Fecal Transplant for Crohn's DiseaseCompletedNCT03078803Phase 2
• The Norwegian Drug Monitoring StudyCompletedNCT03074656Not applicable
• Study of Gut Microbiota in Crohn's Disease Patients Suffering From SpondylarthritisStatus unknownNCT03072836Not applicable
• The SpACE Study - Small Bowel Crohn's Disease and SpondyloarthropathiesCompletedNCT03064815Not applicable
• Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBDWithdrawnNCT03059849Phase 4
• The Role of MSC in the Treatment of Fistulas in Patients With Perianal Crohn's DiseaseStatus unknownNCT03056664Phase 2/3
• Resting Energy Expenditure Evaluation in Subjects With Crohn's DiseaseStatus unknownNCT03054935
• Magnetic Resonance Imaging of Motility in Crohn's 2CompletedNCT03052465Not applicable
• OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut MicrobiomeCompletedNCT03051204
• A Study to Determine the Safety and Immunogenicity of a Candidate MAP Vaccines ChAdOx2 HAV and MVA in Healthy Adult VolunteersCompletedNCT03027193Phase 1
• Comparison of Intracorporeal and Extracorporeal Anastomoses for Minimally Invasive Right ColectomyCompletedNCT03019016
• A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life ConditionsTerminatedNCT03017014
• Diet as Essential Therapy (DIET) for Inflammatory Bowel DiseaseStatus unknownNCT03012542Not applicable
• Effect of UGIR in Adults With Compromised Gut Function and MalabsorptionCompletedNCT03011593Not applicable
• A First Time in Human Study in Healthy Volunteers and PatientsCompletedNCT03010787Phase 1
• Zurich Fistula Cohort StudyStatus unknownNCT03003351
• Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's DiseaseStatus unknownNCT03000296Not applicable
• Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel DiseaseCompletedNCT03000101Not applicable
• Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD PatientsStatus unknownNCT02998827Not applicable
• Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin HospitalCompletedNCT02998398
• Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease.CompletedNCT02997059Phase 2
• GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )CompletedNCT02994836Phase 4
• A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD)CompletedNCT02986724
• Pre-Operative Parenteral Nutrition in Malnourished PatientsWithdrawnNCT02985489Not applicable
• A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's DiseaseWithdrawnNCT02974322Phase 3
• A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's DiseaseCompletedNCT02968108Phase 1
• European Novel Motorized Spiral Endoscopy TrialCompletedNCT02965209Not applicable
• Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using ThalidomideStatus unknownNCT02956538Early Phase 1
• Synergistic Effect of Vedolizumab and PentoxifyllineCompletedNCT02953275Early Phase 1
• Long Term Observational Study of a Vagal Nerve Stimulation Device in Crohn's DiseaseStatus unknownNCT02951650Phase 1/2
• Telemedicine Crohn's Disease and Ulcerative Colitis (TECCU)CompletedNCT02943538Not applicable
• Predictors Favoring the Role of Exclusive Enteral Nutrition in Active Crohn's DiseaseCompletedNCT02942511
• RED-FLAGS Index Validation in Crohn's Disease PatientsStatus unknownNCT02940054
• Prevention of Readmissions at IBD Centres of ExcellenceStatus unknownNCT02931799Not applicable
• The Challenge Study: A Dietary Personalization Protocol for Patients With Crohn's Disease and Deep RemissionTerminatedNCT02930564Not applicable
• Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)Status unknownNCT02926300
• Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory DiseasesCompletedNCT02925351Early Phase 1
• Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's DiseaseWithdrawnNCT02913508Phase 2
• Description of Perianal Lesions in a Cohort of Crohn's Disease PatientsCompletedNCT02899013
• Washed Microbiota Transplantation Improves Nutritional Status of Patients With Crohn's DiseaseStatus unknownNCT02897661Not applicable
• Observational Study Evaluating the Effectiveness of Drug Concentration to Predict the Recapture of Response in Crohn's Disease Patients With Loss of Response ( PRADA )CompletedNCT02896985
• Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's DiseaseCompletedNCT02887287
• Long-term Follow-up of Anal Fistulae in Crohn's Disease Treated With Anti-TNFalpha and Interest of New MRI SequencesCompletedNCT02883296Not applicable
• MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease PatientsTerminatedNCT02882841Not applicable
• Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel DiseasesStatus unknownNCT02878395
• Anticipation Effect on Painful Phenomenons Linked to Rectal Distension for Patients With a Crohn's Disease in RemissionStatus unknownNCT02874495
• Comparing the Quality of Life of Terminal Ileitis Patients With Crohn's Disease Treated With Anti-TNF or Surgical ResectionWithdrawnNCT02872506Not applicable
• Trial of Enhanced Pre-Consent DiscussionCompletedNCT02869880Not applicable
• Comparison of Endoscopy and Diffusion-weighted Enterography-MRI for the Diagnosis of Crohn's Disease Recurrence Following Ileocolic Resection: a Pilot StudyStatus unknownNCT02867540Not applicable
• Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel DiseasesCompletedNCT02862132Not applicable
• Olfactogustatory Perception, Eating Behaviour and Inflammation in Crohn's DiseaseCompletedNCT02859675
• The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel DiseasesStatus unknownNCT02858557Not applicable
• Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by AbscessCompletedNCT02856763
• Reduce Risk for Crohn's Disease PatientsCompletedNCT02852694Phase 4
• Search for New Genetic Mutations Major Effect in Crohn's DiseaseCompletedNCT02851134
• IDeaL Pilot Study - Infliximab Dose to Level: Pilot StudyCompletedNCT02847884
• Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel DiseaseCompletedNCT02846961
• Diet for Induction and Maintenance of Remission and Re-biosis in Crohn's DiseaseCompletedNCT02843100Not applicable
• Study of Photographs of Interest in Training to Obtain Good Reproducibility of the Diagnosis of Perianal Lesions of Crohn's Disease Inspection in Internal GastroenterologyCompletedNCT02842450
• COmparison of MicroBiota AccordIng to Age in Crohn's Disease (COMeBACk)CompletedNCT02839317
• Vedolizumab Post Op StudyWithdrawnNCT02834754Phase 2
• Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's DiseaseCompletedNCT02826330
• Mediterranean Diet as an add-on Therapy for Induction of Remission in Patients With Active Crohn's DiseaseStatus unknownNCT02825316Not applicable
• Effectiveness of Vedolizumab in CD Patients Naïve to Anti-TNFWithdrawnNCT02820493Phase 4
• Prucalopride Prior to Small Bowel Capsule EndoscopyStatus unknownNCT02806206Phase 4
• Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel DiseaseCompletedNCT02801240Not applicable
• Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF TherapyTerminatedNCT02793778Phase 2
• Patient-Centred Innovations for Persons With Multimorbidity - QuebecCompletedNCT02789800Not applicable
• Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel DiseaseCompletedNCT02778464
• Laparoscopy Combined With Enhanced Recovery PathwayStatus unknownNCT02777034Not applicable
• UCB Cimzia Pregnancy Follow-up StudyTerminatedNCT02775656
• Reduced Appetite in Crohn's Disease: The Role of the Brain in the Control of Food IntakeCompletedNCT02772458Not applicable
• Improving the Health Care in Inflammatory Bowel Disease.Active, not recruitingNCT02770599
• Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's DiseaseCompletedNCT02770495Phase 3
• The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral UlcerWithdrawnNCT02769494Phase 3
• Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's DiseaseTerminatedNCT02768532Phase 4
• Osteopathy Non-manipulative in Patients With Crohn's Disease.CompletedNCT02763293Not applicable
• Predictive Model of Clinical Outcomes Using Web-based Self-reporting Symptom Diary for Crohn's DiseaseStatus unknownNCT02760836
• Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction StudyWithdrawnNCT02760615Phase 4
• Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal AnastomosisStatus unknownNCT02752360Phase 1
• A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)CompletedNCT02749630Phase 1

← Crohn Disease overview